{
    "clinical_study": {
        "@rank": "124487", 
        "brief_summary": {
            "textblock": "Four subjects were treated under compassionate use provisions under this study with\n      facilitating cell therapy (FCRx) product manufactured using the CliniMACS (Miltenyi Biotec)\n      device, rather than the Max Sep (Baxter) device."
        }, 
        "brief_title": "Induction of Donor-Specific Tolerance in Recipients of Live Donor Stem Cell Infusion (Compassionate Use)", 
        "condition": "Renal Failure", 
        "condition_browse": {
            "mesh_term": "Renal Insufficiency"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient must be between the ages of 18 and 65 years and meet the institution's\n             criteria for renal transplantation for end-organ failure\n\n          -  Patient is receiving first renal transplant\n\n          -  Patient is receiving a renal transplant only\n\n          -  The crossmatch is negative between donor and recipient\n\n          -  Women who are of child bearing potential must have a negative pregnancy test (urine\n             test is acceptable) within 48 hours of initiating total body irradiation (TBI) and\n             agree to use reliable contraception for 1 year following transplant\n\n          -  Potential donors who are women of child bearing potential must have a negative\n             pregnancy test (urine test is acceptable) within 48 hours prior to receiving\n             Granulocyte colony-stimulating factor (G-CSF)\n\n          -  No evidence of donor-specific antibody presently or historically\n\n        Exclusion Criteria:\n\n          -  Clinically active bacterial, fungal, viral or parasitic infection\n\n          -  Pregnancy\n\n          -  Clinical or serologic evidence of viral infection which would preclude the recipient\n             from receiving a kidney transplant\n\n          -  Previous radiation therapy at a dose which would preclude TBI\n\n          -  Positive crossmatch between donor and recipient\n\n          -  Evidence for immunologic memory against donor\n\n          -  BMI >35 or <18\n\n          -  Re-transplant\n\n          -  Positive serologies for hepatitis B virus (HBV), hepatitis C virus (HCV), HIV"
            }, 
            "gender": "Both", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "January 29, 2014", 
        "id_info": {
            "nct_id": "NCT02051673", 
            "org_study_id": "ICT-7392-Compassionate Use"
        }, 
        "intervention": {
            "description": "Bone marrow will be processed via a new technology which will enrich hematopoietic stem cells and graft facilitating cells. Monitoring for chimerism will be done at key time points.", 
            "intervention_name": "Biological/Vaccine: Enriched Hematopoetic Stem Cell Transplant", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Kidney Transplantation", 
        "lastchanged_date": "January 29, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60611"
                }, 
                "name": "Northwestern Memorial Hospital"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Induction of Donor-Specific Tolerance in Recipients of Live Donor Stem Cell Infusion (Compassionate Use)", 
        "overall_official": {
            "affiliation": "Northwestern Memorial Hospital", 
            "last_name": "Joseph Leventhal, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "No longer available", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02051673"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Louisville", 
        "sponsors": {
            "collaborator": {
                "agency": "Northwestern University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Louisville", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "N/A", 
        "study_type": "Expanded Access", 
        "verification_date": "January 2014"
    }
}